| 000 | 01576 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515094025.0 | ||
| 264 | 0 | _c20080904 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/s00280-007-0625-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBeumer, Jan H | |
| 245 | 0 | 0 |
_aPlasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cAug 2008 |
||
| 300 |
_a457-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aChromatography, Liquid |
| 650 | 0 | 4 |
_aCytidine Deaminase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xblood |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred Strains |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aTandem Mass Spectrometry |
| 650 | 0 | 4 |
_aTetrahydrouridine _xblood |
| 700 | 1 | _aEiseman, Julie L | |
| 700 | 1 | _aParise, Robert A | |
| 700 | 1 | _aFlorian, Jeffry A | |
| 700 | 1 | _aJoseph, Erin | |
| 700 | 1 | _aD'Argenio, David Z | |
| 700 | 1 | _aParker, Robert S | |
| 700 | 1 | _aKay, Brittany | |
| 700 | 1 | _aCovey, Joseph M | |
| 700 | 1 | _aEgorin, Merrill J | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 62 _gno. 3 _gp. 457-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-007-0625-2 _zAvailable from publisher's website |
| 999 |
_c17524826 _d17524826 |
||